KLF8 and neoplasm: In solid tumors, KLF8, on binding to the upstream region of the MDR1, promotes translational activity in the tumour microenvironment under hypoxic conditions and thus, inhibiting apoptosis and augmenting the rate of efflux of the chemotherapeutic agent (Xu et al., 2010).